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ABSTRACT
Research exploring the proteome of Toxoplasma gondii oocysts has gained 
momentum over the past few years. However, little is known about the oocyst’s 
protein repertoires that contribute to differential virulence among T. gondii strains. 
Here, we used isobaric tag for relative and absolute quantitation-based proteomic 
analysis of oocysts of two T. gondii strains exhibiting the virulent PYS (ToxoDB#9) 
phenotype versus the less virulent PRU (Type II, ToxoDB #1) phenotype. Our aim 
was to determine protein expression patterns that contribute to the virulence of a 
particular phenotype. A total of 2,551 proteins were identified, of which 374 were 
differentially expressed proteins (DEPs) (|log2 fold change| ≥ 0.58 and P < 0.05). 
DEPs included 192 increased and 182 decreased proteins. Gene Ontology and KEGG 
pathway analyses revealed a large number of DEPs enriched in various metabolic 
processes. Protein interaction network analysis using STRING identified inosine 
monophosphate dehydrogenase (IMPDH), Bifunctional GMP synthase/glutamine 
amidotransferase protein, Glucose-6-phosphate 1-dehydrogenase, and Citrate 
synthase as the top four hubs. Of the 22 virulence proteins commonly expressed in 
the oocysts of the two strains, 13 and 2 proteins were increased in PYS strain and 
PRU strain, respectively. Also, 10 and 3 of the 22 identified oocyst wall proteins 
showed higher expression in oocysts of PRU strain and PYS strain, respectively. These 
findings revealed new proteomic differences in the oocysts of T. gondii strains of 
different genotypic backgrounds.
INTRODUCTION
The apicomplexan protozoan parasite Toxoplasma 
gondii has a remarkable ability to infect a wide range of 
mammals, birds and humans [1–4]. Its indirect lifecycle 
involves asexual phase in the intermediate vertebrate 
host and sexual phase that occurs exclusively in the 
intestinal epithelium of the definitive felid host. T. gondii 
undergoes stage transformation during its development 
from tachyzoite to bradyzoite in the intermediate host 
to oocyst’s stage in the feline definitive host. Infection 
can occur via ingestion of the cat-borne oocysts through 
contaminated food or water, ingestion of cysts in the 
tissues of an infected intermediate host or transplacentally 
from infected mothers to their offspring [5]. The ability 
of the different forms of the parasite’s life cycle, in 
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particular the oocyst stage, to adapt to and interact with 
various niches inside and outside the host is essential for 
successful colonization and infection [6]. Oocysts have 
an exceptional ability to adapt to adverse environmental 
conditions outside the host [7]. They can remain viable 
for at least 1 year at 4ºC [8]. Oocysts remained viable 
for at least 4.5 years in fresh water and 2 years in marine 
water [9]. Exposure to ultraviolet irradiation at doses 
even exceeding those used to treat water did not fully 
inactivate T. gondii oocysts [10]. Sodium hypochlorite and 
ozone, two chemicals commonly used to treat sewage and 
drinking water, failed to inactivate all infective oocysts 
[11]. Interestingly, clinical illness can be more severe 
when hosts acquire the infection through ingestion of 
oocysts [12].
The clinical consequence of T. gondii infection in 
human ranges from asymptomatic to debilitating or even 
life threatening. There are likely many reasons for these 
differences. T. gondii displays a high degree of genetic 
diversity and includes strains with distinct virulence 
potentials. Previous studies identified three clonal lineages 
of T. gondii that exhibit different virulence phenotypes in 
mice, with type I strains are lethal in mice, but type II 
and III strains are less virulent [13–14]. In addition to 
the parasite genotype and virulence [13–16], the age and 
immune status of the infected host [4], and stage of the life 
cycle causing infection [12] were all found to influence 
the severity of toxoplasmosis. Also, the pathogenicity 
of T. gondii strains has been found to be correlated with 
their migratory capacity, the growth rate in vitro and 
the parasite loads in mice [15], and polymorphism and 
differential expression of the dense granule and rhoptry 
proteins [16]. Despite significant progress made in recent 
years in understanding the molecular basis of different 
pathogenic behaviors of distinct T. gondii genotypes, the 
mechanisms that underpin differences in the outcome of 
infection are not completely known.
In recent years, interests in T. gondii oocysts have 
increased due to their important role in the transmission 
of T. gondii to new hosts and ecosystems [17], and because 
of their links to increased infections in marine mammals 
and water-borne outbreaks in humans [18]. Transcriptomic 
and proteomic studies addressing the molecular structure 
of oocysts have been reported [19–22]. Proteins uniquely 
expressed in the oocysts have been identified [19–21] 
and proteins that mediate the adaptation of oocysts to 
nutrient-poor and stressing extracellular environment have 
been discovered [23]. Additionally, proteomic changes 
that occur during oocyst sporulation have been revealed 
[24–25]. However, knowledge of the differentially 
expressed proteins that promote virulence between strains 
of different genotypes is still limited. The availability 
of phenotypically distinct strains – virulent type I strain 
and less virulent type II strain of T. gondii – provides 
the opportunity for identifying strain-specific virulence 
factors. In the present study, we compared oocyst’s protein 
expression of the virulent ToxoDB#9 (PYS) strain and 
the less virulent ToxoDB#1 (PRU) strain using iTRAQ 
(isobaric tag for relative and absolute quantitation)-based 
LC-MS/MS analysis. Our results revealed genotype-
specific differences in the proteomes of oocysts of the two 
genotypic variants of T. gondii oocysts. 
RESULTS AND DISCUSSION
The aim of the study was to compare the proteomic 
profiles of virulent PYS strain with avirulent PRU 
T. gondii strain using quantitative iTRAQ-based proteomic 
and bioinformatic analyses. We tested whether there are 
phenotype-specific differentially expressed proteins 
that promote virulence and/or tolerance of the oocysts 
to environmental conditions. A total of 2,551 proteins 
were identified, of which 374 were differentially 
expressed proteins (DEPs) between the two parasite 
strains. Interestingly, about half of the GO terms under 
biological process and 12 pathways in the top 27 enriched 
KEGG pathways were related to metabolic activities, 
underscoring the roles of metabolism in the observed 
differences between the two parasite strains.
Identification and expression of proteins
A total of 404,046 spectra were obtained, of which 
86,777 spectra were identified using MASCOT Server 
2.4.0 (Matrix Science). Also, 51,728 distinct peptides 
were identified and 2,551 proteins were detected after 
grouping with unused score ≥ 1.3 and confidence value 
> 95%. The variation coefficients between the two 
biological replicates covered 99% of the identified proteins 
when the coefficient of variation (CV) < 50% (Figure 1). 
The results of hierarchical clustering analysis of the two 
biological replicates (each contained two pooled technical 
replicates) are shown in Figure 2. Cluster of orthologous 
group (COG) analysis divided the identified proteins into 
26 categories. As shown in Figure 3, translation, ribosomal 
structure and biogenesis; posttranslational modification, 
protein turnover, chaperones; general function prediction 
only; signal transduction mechanisms; and energy 
production and conversion were the five categories with 
the most identified proteins. 
DEPs were identified by comparing the relative 
protein expression values between PYS strain and PRU 
strain. A total of 374 proteins were classified as DEPs 
(|log2 fold change| ≥ 0.58 and P < 0.05), of which 192 
were increased and 182 were decreased (Supplementary 
Table 1 and Supplementary Table 2). GTP-binding 
protein lepA (TGME49_307980), Toxoplasma gondii 
family D protein (TGME49_271590), TGME49_294600, 
TGME49_205090, and toxofilin (TGME49_214080) were 
the top five increased proteins. By contrast, the top five 
mostly decreased proteins were dense granule protein 
GRA7 (TGME49_203310), TGME49_203890, rhoptry 
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protein ROP5 (TGME49_308090), Zn-containing alcohol 
dehydrogenase (TGME49_311780), and nudix-type motif 
9 isoform a family protein (TGME49_247220). 
Functional annotation of DEPs
To elucidate the biological roles of the DEPs between 
oocysts of PYS and PRU strains, GO enrichment analysis 
using GOseq R package was performed. The differentially 
increased and decreased proteins were classified into 
three GO categories, namely biological process, cellular 
component and molecular function. The top 10 most 
abundant GO terms in the three categories are presented 
for increased and decreased proteins (Figure 4A–4B). 
The top five enriched GO terms for increased proteins 
under biological process included small molecule 
metabolic process, cellular protein modification process, 
biosynthetic process, cellular nitrogen compound 
metabolic process, and translation. By contrast, cellular 
protein modification process, cellular nitrogen compound 
metabolic process, biosynthetic process, carbohydrate 
metabolic process, and small molecule metabolic process 
were the top five abundantly enriched terms for the 
decreased proteins. 
The top three increased GO terms of the cellular 
component category included intracellular, cytoplasm 
and protein complex, whereas the top three decreased 
terms included extracellular region, cytoplasm and 
cell. In the category of molecular function, ion binding 
was the most significantly enriched GO term. KEGG 
pathway enrichment analysis revealed 164 DEPs, which 
had a KEGG Orthology (KO) ID and were related to 
51 pathways. The 27 highly enriched pathways are 
represented in Figure 5. The 10 most significantly 
enriched of which were metabolic pathways, biosynthesis 
of secondary metabolites, biosynthesis of antibiotics, 
carbon metabolism, biosynthesis of amino acids, Citrate 
cycle (TCA cycle), peroxisome, ribosome, propanoate 
metabolism, and valine, leucine, and isoleucine 
degradation.
Differences in the expression of virulence factors 
A number of virulence factors of T. gondii oocysts 
have been shown to be increased during sporulation and 
these have been linked to the infectivity of sporulated 
oocysts [25]. In our study, we detected differences in the 
expression levels of these virulence proteins between 
sporulated oocysts of PYS and PRU strains. Among 
the 22 virulence proteins commonly expressed in the 
sporulated oocysts of PYS strain and PRU strain, only 
serine-threonine phosphatase 2C (PP2C) and rhoptry 
protein ROP16 (ROP16) had a higher expression level 
in the PRU strain. By contrast, 13 virulence factors, 
including dense granule protein GRA6 (GRA6), rhoptry 
neck protein RON4 (RON4), microneme protein MIC3 
(MIC3), rhoptry protein ROP2A (ROP2A), dense granule 
protein GRA1 (GRA1), rhoptry neck protein RON5 
(RON5), rhoptry protein ROP18 (ROP18), microneme 
protein MIC2 (MIC2), apical membrane antigen AMA1, 
microneme protein MIC4 (MIC4), microneme protein 
MIC6 (MIC6), rhoptry protein ROP5 (ROP5), and dense 
granule protein GRA7 (GRA7) were upregulated in the 
PYS strain. Furthermore, the level of expression of the 
following seven virulence proteins did not show any 
significant difference between the two strains: rhomboid 
protease ROM4 (ROM4), V-type H(+)-translocating 
pyrophosphatase (VP1), sporozoite protein with an altered 
Figure 1: iTRAQ coupled with LC-MS/MS analysis of sporulated oocysts of ToxoDB#9 (PYS) strain and ToxoDB#1 
(PRU) strain. The x-axis represents coefficient of variation (CV) values. The left y-axis represents the number of proteins and the right 
y-axis represents the cumulative percentage of proteins (red lines). 
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thrombospondin repeat (SPATR), microneme protein 
MIC1 (MIC1), photosensitized INA-labeled protein 
PHIL1 (PHIL1), microneme protein MIC8 (MIC8), and 
rhoptry neck protein RON2 (RON2) (Figure 6). These 
results indicate that sporulated oocysts of the virulent 
PYS strain express more virulence factors than sporulated 
oocysts of the less virulent PRU strain.
Expression of oocyst wall proteins
Oocyst wall proteins play important roles in the 
environmental tolerance of T. gondii oocysts and can 
protect the sporozoites from adverse conditions outside 
in the environment and inside the host [24]. The protein 
profile of T. gondii oocyst wall has already been identified 
Figure 2: Hierarchical clustering of the relative abundance of oocyst’s proteins of PYS strain versus PRU strain. Each 
column represents one protein. Rows represent the pooled samples of the two technical replicates, TRP1 and TRP2. The expression levels 
of the proteins are shown in red (increase) and blue (decrease) colors.
Figure 3: Distribution of cluster of orthologous groups (COG) analysis of the indentified proteins. The y-axis represents the 
number of proteins. The x-axis represents different COG classes. A to Z represent: RNA processing and modification; Chromatin structure 
and dynamics; Energy production and conversion; Cell cycle control, cell division, chromosome partitioning; Amino acid transport and 
metabolism; Nucleotide transport and metabolism; Carbohydrate transport and metabolism; Coenzyme transport and metabolism; Lipid 
transport and metabolism; Translation, ribosomal structure and biogenesis; Transcription; Replication, recombination and repair; Cell 
wall/membrane/envelope biogenesis; Cell motility; Posttranslational modification, protein turnover, chaperones; Inorganic ion transport 
and metabolism; Secondary metabolites biosynthesis, transport and catabolism; General function prediction only; Function unknown; 
Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport; Defense mechanisms; Extracellular structures; 
Mobilome: prophages, transposons; Nuclear structure; Cytoskeleton, respectively. 
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[27–28]. However, in the present study we identified 
22 oocyst wall proteins and analyzed their differential 
expression between two distinct genotypic variants of 
T. gondii oocysts. As shown in Table 1, 10 oocyst wall 
proteins were increased and three were decreased. Roughly 
half of the oocyst wall proteins had higher expression level 
in PRU oocysts compared with PYS oocysts. Only three 
oocyst wall proteins were overexpressed in PYS oocysts 
compared with PRU oocysts. The other nine oocyst 
proteins showed no significant difference between the two 
parasite strains. These discrepancies in the expression of 
oocyst wall proteins are likely related to differences in the 
ability of oocysts of PYS strain and PRU strain to survive 
in the environment.
Table 1: Differential expression of oocyst wall proteins of Toxoplasma gondii
Gene ID Protein Description CV AVE Differential Expression 
TGME49_235315 PAN domain-containing protein 0.0645 2.4260 Up
TGME49_209610 oocyst wall protein OWP2 (OWP2) 0.1685 2.4252 Up
TGME49_286250 hypothetical protein 0.1774 2.2303 Up
TGME49_232170 hypothetical protein 0.1143 2.2166 Up
TGME49_235390 PAN domain-containing protein 0.0756 1.8167 Up
TGME49_209470 hypothetical protein 0.0584 1.7690 Up
TGME49_320530 hypothetical protein 0.3891 1.6981 Up
TGME49_281590 hypothetical protein 0.1065 1.6710 Up
TGME49_253150 hypothetical protein 0.1386 1.5380 Up
TGME49_294820 type I fatty acid synthase 0.1292 1.5107 Up
TGME49_316550 hypothetical protein 0.1300 1.2186 N
TGME49_268310 oocyst wall protein OWP3 (OWP3) 0.0640 1.1597 N
TGME49_269380 hypothetical protein 0.1047 1.1517 N
TGME49_248810 nuclear factor NF7 0.1110 1.1005 N
TGME49_254430 microneme protein 0.0239 0.9752 N
TGME49_204420 oocyst wall protein OWP1 (OWP1) 0.0374 0.9513 N
TGME49_203500 Alanine dehydrogenase/pyridine nucleotide 
transhydrogenase domain-containing protein
0.1033 0.9247 N
TGME49_237080 hypothetical protein 0.2250 0.8431 N
TGME49_258910 hypothetical protein 0.1331 0.5933 Down
TGME49_319890 hypothetical protein 0.2363 0.5931 Down
TGME49_306050 hypothetical protein 0.1883 0.5412 Down
TGME49_287250 hypothetical protein 0.5441 0.5079 N
Abbreviations: CV: coefficient of variation; AVE: average expression value of two biological replicates; Up: increased; 
Down: decreased; N: non-significant change.
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Protein-protein network construction
The protein-protein interaction (PPI) (combined 
score > 0.9) networks of the DEPs were built using 
Cytoscape software (Figure 7). The interaction network 
included 102 nodes and 271 edges. The degrees of 
interaction were defined to determine the number of 
neighbors that a node is directly linked to, and nodes with a 
Figure 4: Gene Ontology (GO) distribution of the differentially expressed proteins (DEPs). The top 10 enriched GO terms 
under Biological Process, Cellular Component and Molecular Function for (A) increased proteins and (B) decreased proteins.
Figure 5: KEGG pathway analysis of the differentially expressed proteins (DEPs). The horizontal axis represents the 
significantly enriched KEGG pathways. The left y-axis represents the number of DEPs and the right y-axis represents logarithmic corrected 
p-values for significant overrepresentation [–log10(p–value)].
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high degree of interaction with other proteins were defined 
as ‘hub’ proteins. The significant hub proteins were inosine 
monophosphate dehydrogenase (IMPDH), Bifunctional 
GMP synthase/glutamine amidotransferase protein 
(GMP synthase), Glucose-6-phosphate 1-dehydrogenase 
(G6PD), and Citrate synthase (CS). All these protein hubs 
are known to play important roles in various metabolic 
processes. For example, IMPDH and GMP synthase are 
key enzymes in the synthesis of guanine nucleotides and 
have been considered good therapeutic targets [29–30]. 
Likewise, G6PD and the mitochondrial CS play a role in 
glycolysis and carbohydrate metabolism. The results of 
qPCR validation of these four hub proteins were consistent 
with the proteomic data (Figure 8). The expression level 
of G6PD and GMP were lower and the expression level of 
IMPDH and CS were higher in the PYS strain compared 
to the PRU strain.
In conclusion, we employed iTRAQ-based 
proteomic approach to profile the proteomic differences 
in T. gondii oocysts between the virulent PYS strain and 
the less virulent PRU strain. A total of 2,551 proteins were 
identified, of which 374 were differentially expressed. 
KEGG pathway enrichment analysis revealed that the 
most enriched pathways were related to metabolism and 
bioenergetics. While PYS oocysts showed significant 
increase in the expression of virulence-related proteins 
compared to PRU oocysts, oocyst wall proteins were 
highly expressed in PRU oocysts compared with PYS 
oocysts. Further research is needed to determine how these 
differentially expressed proteins contribute to the virulence 
of PYS strain and the environmental endurance of PRU 
strain. These findings contribute to our understanding 
of the virulence determinants of T. gondii strains of 
different genotypes and may facilitate the identification 
of new therapeutic targets for prevention and control of 
toxoplasmosis.
MATERIALS AND METHODS
Ethics statement 
All animal protocols were reviewed and approved 
by the Animal Administration and Ethics Committee of 
Lanzhou Veterinary Research Institute, Chinese Academy 
of Agricultural Sciences. Animals were purchased 
from Laboratory Animal Center of Lanzhou Veterinary 
Research Institute. The study was performed in strict 
accordance with the recommendations set forth in the 
Animal Ethics Procedures and Guidelines of the People’s 
Republic of China. All efforts were made to minimize 
animal suffering and to reduce the number of animals used 
to produce T. gondii parasites.
Production and purification of sporulated 
oocysts
The virulent PYS (ToxoDB#9 genotype) and less 
virulent Prugniuad (PRU; ToxoDB #1) strains were used 
in the present study because ToxoDB#9 (Chinese 1) is the 
predominant T. gondii genotype in Asia and T. gondii type 
Figure 6: Heat map clustering of the intensities of the differentially expressed (DE) virulence proteins of oocysts 
between PYS strain and PRU strain. Expression values were log2-transformed and were annotated based on a gradient color scheme. 
The x-axis represents the logogram of virulence proteins. The TRP1 and TRP2 in y-axis represent technical replicates 1 and 2, respectively. 
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II is the most prevalent genotype in cats. Both strains are 
routinely maintained in our laboratory. Briefly, 16-week-
old female guinea pigs were intraperitoneally inoculated 
with 105 tachyzoites of PYS strain. One month after the 
inoculation, guinea pigs showed lethargy, loss of appetite, 
panting, and diarrhea. Then, animals were euthanized and 
the cysts in their brain and muscle tissues were collected 
and used to infect specific-pathogen-free kitten. Feces 
from the infected kitten was collected daily and examined 
by zinc sulfate double centrifugation to detect the excreted 
oocysts. The kitten was tested by indirect fluorescent-
antibody test prior to infection to ensure that they were 
seronegative for T. gondii antibodies. The PRU strain 
was maintained via oral passage of cysts in six-week-old, 
female BALB/c mice. One week postinfection, infected 
mice exhibited reduced appetite, ruffled fur and head 
tilting. Specific-pathogen-free, 10-week-old, kitten was 
orally inoculated with 200 cysts and its feces was collected 
daily and examined as described above to detect oocysts 
of the PRU strain. 
Oocysts of PYS and PRU strains were isolated 
from the cat feces by filtering fecal suspension through 
a tea strainer (250-μm pore size). Then, the fecal filtrates 
were pelleted by centrifugation at 60 g for 15 min. The 
supernatant was discarded and the pellet was washed 3× 
with phosphate-buffered saline (PBS). After discarding the 
supernatant, the pellet was suspended in sucrose solution 
to concentrate the oocysts. Following sucrose flotation, a 
cesium chloride (CsCl) density gradient method was used 
to purify T. gondii oocysts as described previously [26]. 
To induce sporulation, the purified oocysts were mixed 
with 2% H2SO4 and were aerated on a shaker at ambient 
temperature for 7 days. Then, sporulated oocyst were 
washed twice with 0.85% saline, mixed with 2% H2SO4 
and stored at 4°C until analysis. Prior to use, oocysts were 
washed 3× in PBS to remove sulfuric acid and restore 
neutral pH.
Protein extraction and iTRAQ labeling
Total protein was extracted from an equal number 
(~107) of sporulated oocysts of PYS and PRU strains. 
Following centrifugation at 350 g for 15 min, oocyst’s 
pellets were suspended in a radioimmunoprecipitation 
Figure 7: Constructed protein-protein interaction (PPI) networks of the DEPs. PPI networks of the differentially expressed 
proteins (DEPs) were predicted using STRING and were illustrated using Cytoscape software. Nodes represent DEPs and edges represent 
interactions between two proteins. Red- and green-colored nodes represent products of increased and decreased DEPs, respectively. The 
node size indicates high (large) or low (small) degree of interaction. Proteins that are associated to each other are linked by an edge. 
The color of the edge indicates the combined interaction score (edge score).
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assay (RIPA; 50 mM Tris-HCl, 150 mM NaCl, 1% SDS, 
0.1% Trionx-100 and 1% SDC pH 8) buffer supplemented 
with phenylmethylsulfonyl fluoride (PMSF). The oocyst’s 
suspensions were sonicated on ice and pelleted at 10,625 
g for 20 min at 4°C. The supernatant was collected and 
the protein concentration was measured by BCA assay 
(QuantiProTM BCA Assay Kit, Sigma). About 100 μg 
protein of each sample was reduced, alkylated, and then 
precipitated by the methanol/chloroform precipitation 
method. Firstly, 4 μL of the Reducing Reagent were 
added into each sample followed by incubation at 60°C 
for 1 hr. Then, the sample was mixed with 2 µL Cysteine-
Blocking Reagent and kept at ambient temperature for 
10 min. Following rinsing of the 10KD millipore with 
70% ethanol and deionized water, the protein solution 
was poured into millipore and centrifuged at 13,400 g for 
20 min. Solution at the bottom of millipore was discarded 
and the millipore was centrifuged with 100 µL 0.25 M 
TEAB (tetraethylammonium bicarbonate) 3× at 13,400 g 
for 20 min. The protein pellets were reconstituted in 50 μL 
of 6M urea/50 mM TEAB with sonication and digested 
in 2% trypsin overnight (Promega). Then, peptides were 
labeled with 8-plex iTRAQ reagents (113, 114, 119, 121) 
according to the manufacturer’s instructions (AB Sciex, 
USA). About 150 µL isopropyl alcohol were added into 
labeling reagent, and the mixture was added into the 
samples and incubated for 2 hr at ambient temperature. 
After termination with deionized water and centrifugation, 
samples were dried and maintained at –80°C until use.
Strong cation exchange (SCX) fractionation and 
LC-MS/MS analysis 
The iTRAQ labeled peptides were mixed in equal 
amounts and fractioned by a high performance liquid 
chromatography (HPLC) system using Phenomenex 
columns (Gemini-NX 3u C18 110A; 150*2.00 mm). 
The dried peptides were dissolved in 100 μL buffer A 
(20 mM NH4HCO3 in 3% acetonitrile, pH 10), thoroughly 
mixed and were then loaded onto Ultremex SCX column. 
Fractions were collected at a flow rate of 1mL/min with 
buffer B (20 mM NH4HCO3, pH 10) at gradients of 0–8% 
for 5 min; 8–45% for 25 min; 45–80% for 15 min; and 
80–100% for 5 min. Twenty-four fractions were collected 
and acidified with 50% Trifluoroacetic acid (TFA). The 
peptide fractions were dried using vacuum centrifugation 
and reconstituted in 0.1% formic acid and 2% acetonitrile. 
Then, peptides were centrifuged at 13,447 g for 20 min 
and supernatant was transferred into analytical columns to 
be identified with an online Q Exactive system (Thermal 
Scientific). The first grade MS parameters included scan 
range 350 to1800 m/z with a resolution set at 70,000 
with a maximum injection time 40 ms. The second grade 
MS spectra were acquired in a resolution of 17,500 with 
60 ms maximum injection time and the 20 top precursors 
for each MS cycle were selected.
Protein quantitation 
Mascot generic format (.mgf) data file transformed 
from raw MS data by Proteome Discoverer™ 1.4 
were queried to T. gondii ME49 strain database (http://
www.ToxoDB.org/common/downloads/release-10.0/
TgondiiME49/fasta/data/), which contains 8,322 protein 
sequences. Proteins were further identified and quantified 
with ProteinPilotTM Software 4.5 (AB SCIEX). The 
parameters for identification and quantification were set 
as follows: FDR < 0.01 for identification of peptides and 
proteins; confidence level of 95% or unused confidence 
score larger > 1.3 for quantification. Proteins with fold 
Figure 8: Validation of the relative abundance of the top four hub DEPs by qPCR. x-axis shows different DEPs and y-axis 
shows log1.5 fold change values. 
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change ratios ≥ 1.5 or ≤ 0.67 were designated as increased 
or decreased proteins, respectively. 
Bioinformatics analysis
To gain insight into the biological functions of 
DEPs, gene ontology (GO) classification and enrichment 
analyses (http://www.geneontology.org) were performed. 
GO provides a framework for functional annotation 
and classification of the protein expression data. DEPs 
were categorized into three main groups: molecular 
function, biological process and cellular component. 
Additionally, Kyoto Encyclopedia of Genes and 
Genomes (KEGG; http://www.genome.jp/kegg/) pathway 
enrichment analysis was performed to map the potential 
pathways of the DEPs. Hierarchical clustering analysis 
and presentation was performed with Cluster 3.0 and java 
Tree view, respectively. The detection of key protein-
interacting ions in the PPI networks was important for the 
identification of the mechanisms and factors that underpin 
the virulence of T. gondii oocysts. We utilized the Search 
Tool for the Retrieval of Interacting Genes/Proteins (http://
www.string-db.org/), a database of known and predicted 
protein interactions, to construct the PPI network and then 
visualized the distribution characteristics of increased and 
decreased DEPs in the network with Cytoscape software, 
version 3.2.0.
Quantitative real-time PCR (q-PCR) validation 
Q-PCR was employed to confirm the gene 
expression of the identified four hub proteins. TRIzol 
method was used to extract total RNA from sporulated 
oocysts of the PYS and PRU strains, respectively, 
according to the manufacture’s instruction (Invitrogen). 
RNA templates were reverse transcribed to cDNA using a 
reverse transcription kit (Promega). The T. gondii β-actin 
was chosen as an endogenous reference gene to normalize 
all q-PCR data. Q-PCR reactions were performed on the 
Rotor-Gene Q (QIAGEN) with SYBR Green GoTaq® 
qPCR Master Mix (Promega). Primers used in this study 
are shown in Table 2. The condition performed in q-PCR 
cycle were as follows: 95°C for 2 min followed by 
40 cycles of 95°C for 15 s, 60°C for 30 s, 72°C for 30 s. 
The 2−ΔΔCT method was applied to calculate the relative 
gene expression [31].
Data and materials availability 
All the mass spectrometry data have been submitted 
to the ProteomeXchange Consortium with identifier 
PXD005928.
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Table 2: Genes and primers used in qPCR validation
Gene Primer name Primer sequence (5′ to 3′)
β-actin β-actin-F CGAGAGGCTGACCAAGGAAC
β-actin-R CTGCTGGAAGGTGGAGAGAGA
G6PD G6PD-F GACGCCTCTGCCGATTTACT
G6PD-R TCGCTTCCCTTCGCATCT
GMP synthase GMP synthase-F GGACTTTATGACGGCTGACTGG
GMP synthase-R TGATGCCCTTGACTTCGTTG
IMP IMPDH-F GAAACTCTGCCTCCTCCTCTC
IMPDH-R AAGACACCCACAAGCCAAAC
CS CS-F CCGCAACGCTTAGGAGACTA
CS-R TACAGGGATTGGCTTCTGGA
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